Duchenne’s diseaseTranslarnaEuropean Commissionataluren
…onditional marketing authorisation for Translarna (ataluren) in Duchenne’s disease due to lack of efficacy after 11 years in the market.…
1articles mentioning diseases
1disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: Duchenne’s disease ×
Duchenne’s disease
This disease is selected. Its supporting articles are shown below.